Ronald Blue Trust, Inc. Astrazeneca PLC Transaction History
Ronald Blue Trust, Inc.
- $7.7 Billion
- Q4 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 19,767 shares of AZN stock, worth $1.49 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
19,767
Previous 27,712
28.67%
Holding current value
$1.49 Million
Previous $1.82 Million
28.65%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding AZN
# of Institutions
1,358Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.55 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.09 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.83 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.79 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.81 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $234B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...